This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alzheimer's Association Applauds The Obama Administration For Dedication Of New Resources To Alzheimer's Epidemic

- Alzheimer's Association Statement -

WASHINGTON, April 10, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Association commends the Obama Administration for dedicating an additional $100 million within the President's FY 2014 budget toward the fight against Alzheimer's and the implementation of the National Plan to Address Alzheimer's Disease. These new resources will be used to fund research, awareness, education and outreach, and caregiver support.

"In addition to the human suffering caused by the disease, Alzheimer's is creating an enormous financial strain on the health care system, families and the federal budget," said Harry Johns, President and CEO of the Alzheimer's Association. "Last year's creation of the first-ever National Alzheimer's Plan with coordinated, measurable outcomes was a critical step, but unless there are resources to implement the Plan and the will to abide by it, we cannot hope to make sufficient progress."

According to the Alzheimer's Association 2013 Alzheimer's Disease Facts & Figures report, Alzheimer's currently costs the nation $203 billion annually with projections to reach $1.2 trillion by 2050. The direct cost of Alzheimer's and related dementia is greater than any other condition in the U.S., including heart disease and cancer, according to a recent study in the New England Journal of Medicine. Over the next 40 years, caring for people with Alzheimer's and related dementias will cost $20 trillion – enough to pay off the national debt and still send $10,000 to every man, woman and child in the America. Two-thirds of this amount will be paid by Medicare and Medicaid.

Even with this information, however, for every $31,000 Medicare and Medicaid spends on caring for individuals with Alzheimer's, the National Institutes of Health (NIH) spends only $100 on research to change this trajectory. The President's budget recognizes that these programs are linked – investments in Alzheimer's research today will result not just in better lives for millions, but a much sounder financial future for our nation as well. In fact, a disease-modifying or preventive therapy would save billions of dollars in health care costs. If a treatment became available in 2015 that delayed onset of Alzheimer's for five years (a concept similar to anti-cholesterol drugs), quality of life would improve significantly and savings would be seen almost immediately, with Medicare and Medicaid spending reduced by $42 billion just in the year 2020.

"Alzheimer's is not normal aging, but because age is the biggest risk factor the graying of America threatens to bankrupt the nation. If we're going to succeed in changing the trajectory of this epidemic, we must provide scientists with the resources they need," said Johns.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.64%
FB $117.43 -0.96%
GOOG $692.36 -0.84%
TSLA $232.32 -3.92%
YHOO $36.01 -1.42%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs